Agilon Health Inc.
AGL | NYSE
$88.03
-$1.13 (-1.27%)
At close: Sep 21, 2026, 4:00 PM ET
$88.03
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
Market Data
Market Cap $1.47B
Enterprise Value $1.32B
Beta 3.04
Average Volume 379.42K
Shares Outstanding (Diluted) 17.21M
Shares Change YoY 3.98%
Institutional Ownership 0.09%
Exchange NYSE
ISIN US00857U2069
Price Performance
Price Change 1M -7.3%
Price Change 3M -21.2%
Price Change 6M 724.3%
Price Change YTD 422.7%
Price Change 1Y 211.6%
Price Change 3Y -80.9%
Price Change 5Y -87.5%
1M CAGR (ann.) -7.8%
1Y CAGR (ann.) 201.0%
5Y CAGR (ann.) -35.7%
All-Time CAGR -33.0%
Valuation
PE Ratio -5.71
Forward PE 58.44
PEG Ratio -1.47
Forward PEG 0.03
PS Ratio 0.25
Forward PS 0.20
PB Ratio 6.45
P/FCF Ratio -13.07
P/Adj. FCF Ratio -9.21
P/OCF Ratio -20.33
EV/Sales 0.22
EV/EBIT -5.02
EV/EBITDA -5.63
EV/FCF -11.71
Earnings Yield -17.5%
FCF Yield -7.7%
Adj. FCF Yield -10.9%
Financial Health
Net Cash $155.34M
Total Debt $33.45M
Cash & Short-Term Investments $185.63M
Total Assets $1.59B
Current Ratio 1.08
Quick Ratio 1.08
Debt / Equity Ratio 0.15
Debt / EBITDA -0.14
Debt / FCF -0.30
OCF / Debt -2.16
Interest Coverage -79.13
Altman Z-Score 2.22
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin -4.5%
EBITDA Margin -4.0%
Net Profit Margin -4.2%
FCF Margin -1.9%
Adj. FCF Margin -2.7%
SBC / Revenue 0.8%
SBC Impact (per share) -41.9%
Returns
Return on Assets -15.8%
Return on Equity -119.3%
Return on Invested Capital -90.2%
Return on Capital Employed -95.0%
Return on Tangible Assets -16.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 19.1%
Revenue CAGR 5Y 30.8%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 8.0%
EPS CAGR 5Y -23.7%
EPS CAGR 10Y N/A
FCF CAGR 3Y 30.0%
FCF CAGR 5Y 15.4%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 25
EPS Growth Next 3Y 41.1%
Revenue Growth Next 3Y 9.7%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$1.22
EPS Growth Est (next Q) -81.9%
Revenue Est (next Q) $1.46B
Revenue Growth Est (next Q) 1.5%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $94.22
Price Target Upside 7.0%
Cash Flow
Operating Cash Flow $-72.26M
Free Cash Flow $-112.38M
Adj. Free Cash Flow $-159.48M
FCF Per Share -$6.73
OCF Per Share -$4.33
OCF/S Ratio -1.2%
Income Statement
Revenue $5.92B
Gross Profit $82K
Operating Income $-265.15M
EBITDA $-234.01M
Net Income $-251.16M
EPS (Diluted) -$15.41
Revenue / Employee $6.92M
Profit / Employee $-293.41K
Employees 856
Add to Watchlist
Select watchlists to add or remove AGL